Browse studies
Find your next paid study
3 recruiting studies matching your filters
Using Microbiome to Predict Durvalumab Toxicity in Post-CCRT NSCLC Patients (Microdurva)
This phase IV study is hoping to determine if examining the microbiome in non-small cell lung cancer participants who will receive durvalumab can predict treat…
NSCLC, Stage IIILocally Advanced Lung Carcinoma
Jun Zhang, MD, PhDNCT04680377
Phase 3
Personalized Escalation of Consolidation Treatment Following Chemoradiotherapy and Immunotherapy in Stage III NSCLC
The purpose of this study is to test whether or not number of circulating cancer cells detected in the blood can be decreased the by combining the standard tre…
Non Small Cell Lung CancerNSCLC, Stage IIINsclc
Maximilian DiehnNCT04585490
Observational
PILOT for The Precision Exercise Regimen for Cancer Care (PERCC) Study
This study is designed to evaluate whether a precision exercise regimen is feasible to implement within cancer populations, specifically stage II-III primary l…
NSCLC Stage IINSCLC, Stage III
University of UtahNCT06945484